五洲医疗收盘上涨3.41%，滚动市盈率45.71倍，总市值18.54亿元

Core Viewpoint - Wuzhou Medical's stock closed at 27.26 yuan, up 3.41%, with a rolling P/E ratio of 45.71 times and a total market capitalization of 1.854 billion yuan [1] Company Summary - Wuzhou Medical specializes in the research, production, and sales of disposable sterile infusion medical devices and related diagnostic care products, including syringes, infusion and blood transfusion devices, medical puncture needles, and other clinical care products [1] - The company has received various recognitions, including being designated as a national high-tech enterprise and establishing a comprehensive quality management system, certified by TüV SÜD ISO 13485:2016, EU CE product certification, and FDA registration [1] Financial Performance - For the third quarter of 2024, Wuzhou Medical reported operating revenue of 343 million yuan, a year-on-year decrease of 17.38%, and a net profit of 34.34 million yuan, down 36.47% [2] - The company's sales gross margin stood at 17.37% [2] Industry Comparison - The average P/E ratio for the medical device industry is 45.14 times, with a median of 31.99 times, positioning Wuzhou Medical at the 87th rank within the industry [2] - The company's P/B ratio is 2.45, compared to the industry average of 4.84 [2]